ArticlePharmacology research & perspectives2026
Intravenous Tolvaptan Sodium Phosphate Can Fail to Improve Fluid Overload Due to Heart Failure in Patients With Chronic Kidney Disease: A Case Report.
Takaya Uno et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.